InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Asbury Mark, Conseiller Juridique. Officer active across 2 companies, notably Allakos Inc.. In total, 8 filings have been published. History available since 3 June 2021. The latest transaction was filed on 2 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
1,680 shares@ US$5.383.6% of flowCommon StockSEC:0001209191-22-015376:0
140,490 shares0Common StockSEC:0001209191-22-014104:0
26,003 shares0Common StockSEC:0001209191-21-067806
26,003 shares0Common StockSEC:0001209191-21-067806:0
698 shares@ US$91.6623.7% of flowCommon StockSEC:0001209191-21-054721:0
698 shares@ US$91.6623.7% of flowCommon StockSEC:0001209191-21-054721
734 shares@ US$92.2024.5% of flowCommon StockSEC:0001209191-21-038466
734 shares@ US$92.2024.5% of flowCommon StockSEC:0001209191-21-038466:0
8 of 8 declarations
About Asbury Mark
Mark Asbury is the Chief Legal Officer at Allakos Inc. He is responsible for the legal affairs and compliance of the company. His role is essential in navigating the complex regulatory landscape of the biopharmaceutical sector and protecting Allakos's interests. Mark plays a key role in managing legal risks and formulating compliance strategies.
